Home LiteratureArticle Details
PMID: 3612532 Published · ppublish English Comparative Study Journal Article

Selectivity of muscarinic antagonists in radioligand and in vivo experiments for the putative M1, M2 and M3 receptors.

The Journal of pharmacology and experimental therapeutics ·Vol. 242 ·No. 1 ·1987-07-00 ·Pages 257-62

Doods HN, Mathy MJ, Davidesko D, van Charldorp KJ, de Jonge A, van Zwieten PA

Abstract

In the present study we investigated the nature of the muscarinic receptors present in the hippocampus, sympathetic ganglia, atria and salivary glands of the rat. The heterogeneity of the muscarinic receptors was examined both in vivo and in radioligand binding experiments. To study whether the receptors present in the investigated tissues are indeed distinct subtypes we determined the potencies of antagonists in both systems. It is proposed that there are three different binding sites present in hippocampal, atrial and submandibular membranes and we suggest to classify them as M1, M2 and M3, respectively. Both in vivo and in vitro pirenzepine appears to possess high affinity for M1 receptors, whereas 4-diphenylacetoxy-N-methylpiperidine methobromide and dicyclomine show high affinity for both M1 and M3 receptors. AF-DX 116 (11-2[[2-[(diethylamino)methyl]-1-piperidinyl]acetyl]-5, 11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepine-6-one) displayed high affinity for M2 receptors.

MeSH Terms
Animals Dicyclomine/metabolism Ganglia, Sympathetic/metabolism Hippocampus/metabolism Male Myocardium/metabolism Parasympathomimetics Piperidines/metabolism Pirenzepine/analogs & derivatives,metabolism Rats Rats, Inbred Strains Receptors, Muscarinic/metabolism Submandibular Gland/metabolism
Chemicals
Parasympathomimetics Piperidines Receptors, Muscarinic Pirenzepine Dicyclomine 4-diphenylacetoxy-1,1-dimethylpiperidinium otenzepad
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Doods H N
Mathy M J
Davidesko D
van Charldorp K J
de Jonge A
van Zwieten P A
Article Info
Journal
The Journal of pharmacology and experimental therapeutics
Abbr.
J Pharmacol Exp Ther
ISSN
0022-3565
Published
1987-07-00
Pages
257-62
Language
English
Region
United States
NLM ID
0376362
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com